T/CAIA SHO22-2024 Active Group standards

T/CAIA SHO22-2024 Human whole blood glycated hemoglobin HbA1C content using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry

Publish Date: 2024-10-31 Implement Date: 2025-01-31 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us

Price: $ 20.00

Out of stock

Basic Information

Standard Code: T/CAIA SHO22-2024

Standard Type: Group standards

Standard Status: Active

is_force_gb: no

CCS Name: -

ICS Name: Laboratory medicine

Publish Date: 2024-10-31

Implement Date: 2025-01-31

Scope

Main technical content: After fresh or frozen whole blood samples are diluted with a diluent, the red blood cells rupture and release their hemoglobin molecules. These molecules are mixed with a certain proportion of sinapic acid (SA) matrix and evenly applied to the target plate. After drying, the samples are loaded into a matrix-assisted laser desorption/ionization time-of-flight mass spectrometer (MALDI-TOF MS) for detection (with a laser wavelength of 349 nm). The glycated hemoglobin HbA1C content in the samples is quantified using an external standard method.